Chemokines in hematopoiesis

Research output: Contribution to journalReview article

148 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Understanding the regulation of hematopoiesis is important for enhanced efficacy of hematopoietic stem and progenitor cell transplantation. Chemokines influence migration, survival, and other actions of hematopoietic stem and progenitor cells. This article summarizes recent progress in understanding the production and actions of chemokines and chemokine receptors, with an emphasis on the SDF-1/CXCL12-CXCR4 axis. RECENT FINDINGS: The literature from 2006 to the present is replete with information on SDF-1/CXCL12 activity, including induced intracellular signaling in hematopoietic progenitor cells, lymphocytes, other innate immune cells, breast cancer, and other tumor cells, and on production of SDF-1/CXCL12, and CXCR4, as well as on actions/production of other chemokines. Studies describing these intense research areas are discussed. SUMMARY: Chemokine-chemokine receptor interactions are important to hematopoiesis and immune cell function, two highly interactive processes. Recent studies have clarified the role of chemokines and their receptors in regulating hematopoiesis, and agents modulating chemokines are being evaluated in preclinical and clinical studies. Examples of such efforts include inhibition of CD26 for enhanced homing and engraftment of hematopoietic stem and progenitor cells, and the use of the SDF-1/CXCL12-CXCR4 antagonist, AMD3100 for mobilization of hematopoietic stem and progenitor cells and their use for stem cell transplantation.

Original languageEnglish (US)
Pages (from-to)49-58
Number of pages10
JournalCurrent opinion in hematology
Volume15
Issue number1
DOIs
StatePublished - Jan 1 2008

Fingerprint

Hematopoiesis
Hematopoietic Stem Cells
Chemokines
Chemokine Receptors
Hematopoietic Stem Cell Transplantation
Stem Cell Transplantation
Lymphocytes
Breast Neoplasms
Research

Keywords

  • Chemokine receptors
  • Chemokines
  • CXCR4
  • Hematopoiesis
  • Immune cells
  • SDF-1/CXCL12

ASJC Scopus subject areas

  • Hematology

Cite this

Chemokines in hematopoiesis. / Broxmeyer, Hal E.

In: Current opinion in hematology, Vol. 15, No. 1, 01.01.2008, p. 49-58.

Research output: Contribution to journalReview article

@article{e3ccf8c3ea3e404484a987273ad8b127,
title = "Chemokines in hematopoiesis",
abstract = "PURPOSE OF REVIEW: Understanding the regulation of hematopoiesis is important for enhanced efficacy of hematopoietic stem and progenitor cell transplantation. Chemokines influence migration, survival, and other actions of hematopoietic stem and progenitor cells. This article summarizes recent progress in understanding the production and actions of chemokines and chemokine receptors, with an emphasis on the SDF-1/CXCL12-CXCR4 axis. RECENT FINDINGS: The literature from 2006 to the present is replete with information on SDF-1/CXCL12 activity, including induced intracellular signaling in hematopoietic progenitor cells, lymphocytes, other innate immune cells, breast cancer, and other tumor cells, and on production of SDF-1/CXCL12, and CXCR4, as well as on actions/production of other chemokines. Studies describing these intense research areas are discussed. SUMMARY: Chemokine-chemokine receptor interactions are important to hematopoiesis and immune cell function, two highly interactive processes. Recent studies have clarified the role of chemokines and their receptors in regulating hematopoiesis, and agents modulating chemokines are being evaluated in preclinical and clinical studies. Examples of such efforts include inhibition of CD26 for enhanced homing and engraftment of hematopoietic stem and progenitor cells, and the use of the SDF-1/CXCL12-CXCR4 antagonist, AMD3100 for mobilization of hematopoietic stem and progenitor cells and their use for stem cell transplantation.",
keywords = "Chemokine receptors, Chemokines, CXCR4, Hematopoiesis, Immune cells, SDF-1/CXCL12",
author = "Broxmeyer, {Hal E.}",
year = "2008",
month = "1",
day = "1",
doi = "10.1097/MOH.0b013e3282f29012",
language = "English (US)",
volume = "15",
pages = "49--58",
journal = "Current Opinion in Hematology",
issn = "1065-6251",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Chemokines in hematopoiesis

AU - Broxmeyer, Hal E.

PY - 2008/1/1

Y1 - 2008/1/1

N2 - PURPOSE OF REVIEW: Understanding the regulation of hematopoiesis is important for enhanced efficacy of hematopoietic stem and progenitor cell transplantation. Chemokines influence migration, survival, and other actions of hematopoietic stem and progenitor cells. This article summarizes recent progress in understanding the production and actions of chemokines and chemokine receptors, with an emphasis on the SDF-1/CXCL12-CXCR4 axis. RECENT FINDINGS: The literature from 2006 to the present is replete with information on SDF-1/CXCL12 activity, including induced intracellular signaling in hematopoietic progenitor cells, lymphocytes, other innate immune cells, breast cancer, and other tumor cells, and on production of SDF-1/CXCL12, and CXCR4, as well as on actions/production of other chemokines. Studies describing these intense research areas are discussed. SUMMARY: Chemokine-chemokine receptor interactions are important to hematopoiesis and immune cell function, two highly interactive processes. Recent studies have clarified the role of chemokines and their receptors in regulating hematopoiesis, and agents modulating chemokines are being evaluated in preclinical and clinical studies. Examples of such efforts include inhibition of CD26 for enhanced homing and engraftment of hematopoietic stem and progenitor cells, and the use of the SDF-1/CXCL12-CXCR4 antagonist, AMD3100 for mobilization of hematopoietic stem and progenitor cells and their use for stem cell transplantation.

AB - PURPOSE OF REVIEW: Understanding the regulation of hematopoiesis is important for enhanced efficacy of hematopoietic stem and progenitor cell transplantation. Chemokines influence migration, survival, and other actions of hematopoietic stem and progenitor cells. This article summarizes recent progress in understanding the production and actions of chemokines and chemokine receptors, with an emphasis on the SDF-1/CXCL12-CXCR4 axis. RECENT FINDINGS: The literature from 2006 to the present is replete with information on SDF-1/CXCL12 activity, including induced intracellular signaling in hematopoietic progenitor cells, lymphocytes, other innate immune cells, breast cancer, and other tumor cells, and on production of SDF-1/CXCL12, and CXCR4, as well as on actions/production of other chemokines. Studies describing these intense research areas are discussed. SUMMARY: Chemokine-chemokine receptor interactions are important to hematopoiesis and immune cell function, two highly interactive processes. Recent studies have clarified the role of chemokines and their receptors in regulating hematopoiesis, and agents modulating chemokines are being evaluated in preclinical and clinical studies. Examples of such efforts include inhibition of CD26 for enhanced homing and engraftment of hematopoietic stem and progenitor cells, and the use of the SDF-1/CXCL12-CXCR4 antagonist, AMD3100 for mobilization of hematopoietic stem and progenitor cells and their use for stem cell transplantation.

KW - Chemokine receptors

KW - Chemokines

KW - CXCR4

KW - Hematopoiesis

KW - Immune cells

KW - SDF-1/CXCL12

UR - http://www.scopus.com/inward/record.url?scp=36549058333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36549058333&partnerID=8YFLogxK

U2 - 10.1097/MOH.0b013e3282f29012

DO - 10.1097/MOH.0b013e3282f29012

M3 - Review article

C2 - 18043246

AN - SCOPUS:36549058333

VL - 15

SP - 49

EP - 58

JO - Current Opinion in Hematology

JF - Current Opinion in Hematology

SN - 1065-6251

IS - 1

ER -